References
- Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488–94.
- Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5–16.
- Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:89–97.
- Braga FJ, Flamen P, Mortelmans L, Stroobants S, Homans F, Maes A. Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma. Clin Nucl Med 2001;27:642–5.
- Leu H, Kleemann R. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002;4:449–60.
- Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334–49.
- Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791–800.
- Nguyen J, Vasinrapee P, Cook R, Surprenant E, Spieth M, Wilson M. Hepatocellular carcinoma with intravascular extension: Ga-67 scintigraphic findings. Clin Nucl Med 1998;23:171–82.
- Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 2006;5:399–410.
- Lan HY. Role of macrophage migration inhibition factor in kidney disease. Nephron Exp Nephrol 2008;109:79–83.
- Brown FG, Nikolic-Paterson DJ, Metz C, Bucala R, Atkins RC, Lan HY. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol 1999;118:329–36.
- Lolis E, Bucala R. Macrophage migration inhibitory factor. Expert Opin Ther Targets 2003;7:153–64.
- Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor in angiogenesis and the growth of a murine lymphoma. Mol Med 1999;5:181–91.
- Robinson P. Hepatocellular carcinoma: development and early detection. Cancer 2008;4:128–31.
- Khawli LA, Biela B, Hu P, Epstein AL. Comparison of recombinant derivatives Of chimericTNT-3 antibody for the radioimaging of solid tumors. Hybrid Hybridomics 2003;22:1–9.
- Datz FL, Anderson CE, Ahluwalia RJ. The efficacy of indium-111-polyclonal IgG for the detection of infection and inflammation. J Nucl Med 1994;35:74–83.
- Akbar SM, Abe M, Murakami H. Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett 2001;171:125–32.
- Nishio Y, Nishihira J, Ishibashi T. Role of macrophage migration inhibitory factor (MIF) in peripheral nerve regeneration: anti-MIF antibody induces delay of nerve regeneration and the apoptosis of Schwann cells. Mol Med 2002;8:509–20.
- Cvetkovic I, Stosic-Grujicic S. Neutralization of macrophage migration inhibitor factor-novel approach for the treatment of immunoinflammatory disorders. Int Immunopharmacol 2006;6:1527–34.